Organogenesis Holdings (ORGO) Capital Leases (2017 - 2026)

Organogenesis Holdings' Capital Leases history runs 9 years deep, the most recent figure standing at $12.4 million for Q1 2026.

• On a quarterly basis, Capital Leases rose 2906.81% year-over-year to $12.4 million in Q1 2026; TTM through Mar 2026 was $12.4 million, a 2906.81% increase from a year earlier, with the FY2025 full-year figure at $12.8 million, up 1681.06% from the prior year.
• Capital Leases slipped to $12.4 million in Q1 2026 per ORGO's latest filing, from $12.8 million in the prior quarter.
• Across five years, Capital Leases topped out at $12.8 million in Q4 2025 and bottomed at $98000.0 in Q2 2025.
• The 4-year median for Capital Leases is $1.5 million (2024), against an average of $3.1 million.
• Across the five-year window, Capital Leases plunged 92.54% in 2025 and soared 2906.81% in 2026, its largest moves.
• Year by year, Capital Leases stood at $1.9 million in 2023, then tumbled by 61.97% to $718000.0 in 2024, then jumped by 1681.06% to $12.8 million in 2025, then decreased by 3.36% to $12.4 million in 2026.
• Per Business Quant, the three latest ORGO Capital Leases figures stand at $12.4 million (Q1 2026), $12.8 million (Q4 2025), and $2.1 million (Q3 2025).